Early-onset cancers are rising worldwide, and this Cell Perspective argues that cancer prevention must move beyond static risk-factor snapshots toward life-course exposure mapping, tissue-level biology, and dynamic estimates of preventability. The authors propose three linked frameworks to speed discovery of cancer causes and translate those findings into more precise prevention and interception strategies.

8 Apr 2026

Crisis-driven maternal psychological stress can affect fetal development and birth outcomes

Fetal development is a critical stage with effects that can last throughout life. Yet, identifying the effects of maternal psychological stress on the fetus has been difficult, mainly because stressful events often produce psychological and physical consequences that directly affect mothers and their children.

8 Apr 2026

Long-term study links common IBS medications to mortality risk

A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)-including antidepressants-may be associated with a small but measurable increase in the risk of death.

8 Apr 2026

Higher optimism linked to lower dementia risk

Higher optimism is associated with a lower risk of developing dementia, according to a new study in the Journal of the American Geriatrics Society.

8 Apr 2026

ChatGPT delivers clearer PCOS answers than standard resources

ChatGPT outperforms traditional resources in clarity for PCOS information, highlighting its role as a supportive tool in evidence-based healthcare education.

8 Apr 2026

New guidelines and follow-up standards improve pulmonary embolism outcomes

Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the lungs and blocks blood flow.

8 Apr 2026

Antiviral drugs and shingles vaccines tied to lower dementia risk

New evidence links viral infections to dementia risk, suggesting vaccines and antiviral therapies may offer preventive pathways against cognitive decline.

8 Apr 2026

AI models may amplify bias in psychiatric aggression predictions

A first-of-its-kind study led by researchers at the Centre for Addiction and Mental Health (CAMH) has found that artificial intelligence (AI) models used to predict aggressive incidents in acute psychiatric care can reinforce and amplify existing social and structural inequities by overestimating the likelihood of aggression among already marginalized groups.

7 Apr 2026

AI tool predicts Barrett’s esophagus recurrence with high accuracy

A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE) related dysplasia and early esophageal adenocarcinoma.

7 Apr 2026

Pol theta enzyme identified as key driver of cancer resilience

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.

7 Apr 2026

Navigated TMS significantly boosts combat PTSD recovery rates

An advanced version of a procedure using magnetic fields to stimulate brain nerve cells in treating depression was significantly effective for 85% of active military and veterans suffering from combat post-traumatic stress disorder enrolled in a recent study, when added to psychotherapy.

7 Apr 2026

Integrated motor exercise improves core ADHD symptoms and executive function

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood and is marked not only by inattention, hyperactivity, and impulsivity, but also by weaknesses in executive functions such as inhibition, working memory, and cognitive flexibility.

7 Apr 2026

New obesity definition could delay treatment and widen health gaps

The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.

7 Apr 2026

Salaera™ launches to advance the future of breath and gas technologies

Perma Pure and Maxtec today announced their unification under a new parent company, Salaera, forming a global technology platform dedicated to the integrity of breath and gas systems.

From Salaera™ 7 Apr 2026

Prenatal smoking linked to broader mental health issues in children

Children exposed to maternal smoking before birth are more likely to experience behavioral and mental health challenges, according to a large study funded by the National Institutes of Health's Environmental influences on Child Health Outcomes (ECHO) Program.

6 Apr 2026

Novel screening method boosts early diagnosis of leprosy

A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. Researchers at the University of São Paulo (USP) tested the new test in Brazil using blood samples collected during a COVID-19 population survey.

6 Apr 2026

Fecal microbiota transplant can improve survival in severe C. difficile infection

A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant Clostridioides difficile (C. difficile) infection - a life-threatening condition characterized by a sepsis-like state.

6 Apr 2026

Researchers track how youth drinking deaths changed worldwide over 31 years

A global analysis of GBD 2021 data found that youth drinking contributed to 417,198 deaths across 194 WHO member countries and territories between 1990 and 2021, with deaths declining from 13,346 to 10,563 over the period. Boys and young men bore a far higher burden, and most alcohol-attributable deaths were linked to transport injuries, interpersonal violence, and self-harm, with marked disparities across SDI levels and countries.

6 Apr 2026

New compounds reduce inflammation without weakening immune defense

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the body's ability to fight infections intact-a long-sought goal in treating autoimmune diseases.

6 Apr 2026